Douglas S Ingram Sarepta Therapeutics, Inc. (SRPT) insider trading activity
Douglas S Ingram is President & CEO of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 390,307 shares of SRPT, which is worth approximately $50.3 Million. The most recent transaction as insider was on Nov 03, 2023, when has been sold 25,225 shares (Common Stock) at a price of $79.97 per share, resulting in proceeds of $2,017,243. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
390K
0%
3M change
6.91%
12M change
Total Value Held
$50.3 Million
DOUGLAS S INGRAM Transaction History
Also insider at
DSI
Douglas S Ingram
President & CEO
Cambridge, MA